Safety, Tolerability, Pharmacokinetics and Efficacy of LMB763 in Patients With NASH

                                                                                                                                                                                                                 

Study description

The purpose of the present study is to assess the effects of LMB763 with respect to safety, tolerability, and on markers of liver inflammation in patients with NASH

Pathology

Non-alcoholic Statohepatitis NASH

Study type

Clinical trial

Status

Active

Study start date

2017

Funder Type

Industry funded study

Investigator

Dr.ssa med. Benedetta TERZIROLI BERETTA-PICCOLI

Recruitment

Completed

Learn more